Shalby Ltd.

Shalby Ltd.

115.50
INR
-5.10
(-4.23%)
3.35EPS
49.59P/E
18.60BMarket Cap
Shalby Ltd.
BSE:SHALBY
(Bombay Stock Exchange)

Recent

price

115.50

P/E

ratio

49.59

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
20.79
23.79
25.38
26.73
29.92
40.05
42.69
45
39.89
64.71
74.44
86.48
100.56
105.59
105.07
Revenue per Share
1.58
3.61
2.38
3.48
2.75
4.17
2.93
2.55
3.93
5.01
6.3
7.83
0.58
3.48
3.51
Basic EPS, GAAP
7.84
-2.06
5.54
-8.76
-9.04
1.48
4.02
3.3
5.4
-5.23
4.59
-2.56
-7.05
-13.86
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
0.6
0.5
1
1.01
1.21
1.21
- -
- -
Dividend per Share
9.39
13
15.55
20.49
23.28
69.57
72.2
73.99
77.28
81.13
85.89
93.33
92.5
93.49
- -
Book Value per Share
8.58
12.05
14.02
20.27
23.06
68.57
71.07
72.67
75.69
79.19
83.9
86.32
84.95
85.26
- -
Tangible Book Value per Share
108
108
108
108
108
94
108
108
108
108
107
107
107
108
112
Basic Weighted Avg Shares
2,246
2,569
2,742
2,887
3,231
3,779
4,611
4,860
4,309
6,989
7,996
9,282
10,808
11,352
11,762
Sales/Revenue/Turnover
7.41
20.82
17.43
15.88
17.33
16.14
11.33
11.95
12.93
11.82
11.73
13.83
7.21
6.95
6
Operating Margin (%)
272
110
212
113
167
229
332
360
368
429
388
522
658
700
722
Depreciation Expense
171
390
257
376
297
394
317
276
424
541
677
841
62
374
393
Net Income, GAAP
19.73
27.61
42.95
- -
43.16
27.1
37.18
51.37
23.06
31.81
33.68
34.87
96.55
42.73
34.89
Effective Tax Rate (%)
7.62
15.19
9.39
13.02
9.19
10.42
6.87
5.68
9.84
7.74
8.47
9.06
0.58
3.29
3.34
Profit Margin (%)
-92
227
-278
51
65
973
1,075
1,505
1,894
2,764
3,229
2,290
2,026
1,436
- -
Working Capital
4
228
737
1,770
2,382
754
569
531
448
1,007
1,016
2,269
1,753
1,943
- -
LT Debt
1,057
1,434
1,708
2,217
2,508
7,515
7,798
7,992
8,347
8,762
9,276
10,078
9,953
10,057
- -
Total Equity
- -
25.97
12.04
- -
6.75
6.29
3.83
3.24
4.7
5.47
5.8
6.82
0.18
3.24
- -
Return on Invested Capital (%)
- -
28.49
13.06
- -
7.58
6.86
4.21
3.51
5.08
6.01
6.77
7.54
0.82
3.93
- -
Return on Capital (%)
- -
32.27
16.69
19.31
12.56
7.85
4.14
3.49
5.19
6.33
7.51
8.72
0.62
3.74
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
4,002
- -
LT Borrowings
- -
1,529
- -
LT Finance Leases
- -
415
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
108
108
107
Market Capitalization
21,864
13,639
18,596

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
7,193
- -
Cash, Cash Equivalents & STI
- -
842
- -
Accounts Receivable, Net
- -
2,284
- -
Inventories
- -
3,764
- -
Total Current Liabilities
- -
5,757
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
4,002
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.28%
3.86%
1.04%
Free Cash Flow
-12.16%
-53.56%
96.68%
Net Income, GAAP
51.81%
97.05%
500.9%
Sales/Revenue/Turnover
15.91%
22.83%
5.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2,789
2,675
2,756
2,649
10,808
2026
2,964
2,854
2,721
2,874
11,352
2027
3,312
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.37
0.32
-0.17
-1.13
0.58
2026
0.71
0.68
0.16
1.72
3.48
2027
0.98
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1.21
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Business
Shalby Limited (SHALBY.NS) operates a chain of multispecialty hospitals and tertiary care centers primarily in India, offering comprehensive healthcare services across more than 30 specialties including joint replacement surgery, critical care and trauma, spine surgery, neurology and neurosurgery, ortho-oncology, cardiology and minimal invasive cardiac surgery, kidney and liver transplants, medical oncology, pediatrics, ophthalmology, plastic and reconstructive surgery, bariatric surgery, gynecology, IVF, homecare services such as ICU at home and physiotherapy, and specialty clinics for stroke, epilepsy, diabetes, and oncology; the company also manufactures orthopedic implants through its Shalby Advanced Technologies division. Founded in 1994 and headquartered in Ahmedabad, Gujarat, Shalby manages 16 hospitals across 13 cities in eight Indian states with over 2,300 beds, alongside outpatient centers and operations extending to international OPDs in countries like the United States, Japan, Indonesia, Oman, UAE, Bangladesh, Nepal, Kenya, Tanzania, Uganda, and tie-ups in the UAE and Cambodia. Recent developments include the acquisition of a 100% equity stake in Healers Hospital Private Limited in Gurugram for approximately Rs 104 crore in March 2024 to consolidate its northern India presence following the prior majority stake purchase in Sanar International Hospitals (PK Healthcare Pvt Ltd), inauguration of new facilities such as the Shalby Orthopedic Center of Excellence in Rajkot and a Tissue & Bone Bank at Krishna Shalby Hospital in Ahmedabad, strategic clinical trial agreement with Monogram Technologies Inc, US FDA approval for products from its US step-down subsidiary Shalby Advanced Technologies Inc, launch of the innovative TUKS knee implant, and partnerships like MoUs with universities for healthcare management programs and skill development.